Gentian Diagnostics YTD swings to net loss of NOK 8.5 million; YTD sales rise 11% to NOK 144.8 million

PUBT · 2d ago
Gentian Diagnostics YTD swings to net loss of NOK 8.5 million; YTD sales rise 11% to NOK 144.8 million
  • Gentian Diagnostics swung to a year-to-date net loss of NOK 8.5 million; results included a NOK 30.2 million impairment.
  • Third-quarter sales rose 22% year over year to NOK 51.1 million.
  • Operating cash flow climbed 67% year over year to NOK 14.9 million in the third quarter.
  • An assay for a key IVD partner advanced from research to development, while development work with Essange Reagents started.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Gentian Diagnostics ASA published the original content used to generate this news brief on October 20, 2026, and is solely responsible for the information contained therein.